The largest database of trusted experimental protocols

20 protocols using ana 12

1

ANA12 and SGN Cell Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
SGN samples were dissected and plated as described above. After the tissues had adhered to the plate for 5 h at 37 °C, 5% CO2, SGN samples receiving ANA12 had media changed to 50 «L of culture medium containing ANA12 (Tocris Bioscience) at a final concentration of 10 nM. Control samples were incubated overnight without ANA12. ANA12 was stored as stock solution in DMSO at 10 μM at −20 °C. All tissues in both plates were incubated overnight at 37 °C, 5% CO2.
After 24 h, all cultures received 400 nM of DHF, Ris, Ris-DHF, or DMSO alone (control) as described above. SGNs in the ANA12 assay plate additionally received 10 nM ANA12 in culture medium. Cultures was kept at 37 °C, and media was changed every 24 h. After 48 h, the cells were fixed, permeabilized, stained, and evaluated with confocal microscopy as described above.
+ Open protocol
+ Expand
2

Pharmacologically Induced Hypothermia in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
C57Bl6/J wild-type mice, tg37+/− (Mallucci et al, 2002 (link)) and B6;129S2-Ntrk2tm1Bbd/J (Ntrk2+/−) mice (https://www.jax.org/strain/002544) weighing ≥20 g were cooled using 5′-AMP as described (Peretti et al, 2015 (link)). Briefly, mice were intraperitoneally injected with freshly prepared 5′-AMP (0.7 mg per g; Sigma-Aldrich) or saline control. Mice were maintained at room temperature until core body temperature decreased to 25°C (∼60 min). Subsequently, mice were transferred to a refrigerator (5–10°C) and core body temperature lowered to 16–18°C for 45 min. For rewarming, mice were allowed to recover to normal body temperature at room temperature conditions. Cooled samples were collected at the end of the 16–18°C period and rewarmed samples as stated elsewhere in the text. ANA-12 (N-[2-[[(Hexahydro-2-oxo-1H-azepin-3- yl)amino]carbonyl]phenyl]benzo[b]thiophene-2-carboxamide) (Tocris) compound was intraperitoneally injected (0.5 mg/kg in 0.5% DMSO in saline solution) in wild-type and prion-infected mice, twice a day for 2 d before cooling and 2 h before the initiation of the cooling protocol. 7,8-Dihydroxyflavone (7,8-DHF) (Tocris Bioscience) was injected intraperitoneally to C57Bl6/J wild-type mice at 5 mg/kg in 17% DMSO in PBS buffer (Devi & Ohno, 2012 (link)).
+ Open protocol
+ Expand
3

Neuroprotective Mechanisms of Sulfur Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
Male Wistar albino rats (200-250 g) were used for this study, and these were maintained at standard laboratory conditions (40% humidity, a temperature of 24°C-26°C, and 12 hr of light and dark). The experimental protocol was approved by the Institutional Animal Ethics Committee of Tianjin First People’s Hospital (Ethical committee) with ethical approval number: 2019528A65F025. The experiments were performed as per the ethical guidelines. ANA-12, BDNF receptor blocker (Tocris Bioscience, Bristol, UK), diallyl disulfide (Sigma-Aldrich, St. Louis, Missouri) and diallyl trisulfide (Sigma-Aldrich) were used as pharmacological agents. The enzyme-linked immunosorbent assay (ELISA) kits for the quantification of BDNF and Nrf2 were procured from RayBiotech, Peachtree Corners, Georgia.
+ Open protocol
+ Expand
4

Experimental Stimulation of Neuronal Receptors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Slices were incubated with 10 nM E2 (EMD Millipore) or 100 nM G1 (Tocris Bioscience) at 37°C for the indicated periods of time. Alternatively, slices were incubated with 100 nM PPT (Tocris Bioscience) or 10 nM DPN (Tocris Bioscience) for 1 h. Treatment with DHPG (100 µM; Tocris Bioscience) was generally performed 1 h after G1 application and lasted 15 min, unless stated otherwise. In some experiments, slices were pretreated for 30 min with different inhibitors or antagonists, including ANA-12 (50 µM; Tocris Bioscience), cycloheximide (25 µM; Tocris Bioscience), MG132 (25 µM; EMD Millipore), rapamycin (1 µM; Cell Signaling Technology), and G36 (1 µM; Azano Biotech). TrkB-Fc (2 µg/ml; R&D Systems) or IgG-Fc (2 µg/ml; Bethyl Laboratories, Inc.) were preincubated for 1 h before chemical treatment.
+ Open protocol
+ Expand
5

Purification and Characterization of Chemicals

Check if the same lab product or an alternative is used in the 5 most similar protocols
Chemicals and reagents used for the experiments were obtained from Gibco, Thermo Fisher Scientific, Waltham, MA, USA; Sigma Aldrich; and Merk KGaA, Darmstadt, Germany, unless stated otherwise. Thymol (purity > 99%) was purchased from Tokyo Chemical Industry Company Limited (TCI), Tokyo, Japan (Pubchem substance ID: 87572469). Stigmasterol (purity ~95%), nocodazole (purity ~99%), quercetin (purity > 95%) (Pubchem substance ID: 329823865), and paclitaxel (purity > 95%) (Pubchem substance ID: 24277878) were purchased from Sigma-Aldrich, Saint Louis, MO, USA. ANA-12 (Pubchem substance ID: 2799722) was purchased from from Tocris Biosciences, Fischer Scientific, USA.
+ Open protocol
+ Expand
6

Pharmacological Regulation of Synaptic Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
For activating mGluR5, CHPG (Cat. No. 1049 – Tocris Bio-Techne Corporation) a mGluR5 selective agonist was used at a dose of 1mM, whereas for inhibiting NMDAR function, (+)-MK 801 maleate (Cat. No. 0924 Tocris Bio-Techne Corporation) a selective non-competitive antagonist was added at a final concentration of 3uM. Lastly, ANA-12 (Cat. No. 4781 Tocris – BioTechne) that is a TrkB receptor antagonist was added at 1uM.
Pharmacological and psychotropic treatment experiments.
+ Open protocol
+ Expand
7

TrkB Signaling Blockade and Electroacupuncture Modulate Cognitive Function

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice were randomly distributed into EA, ANA-12, and ANA-12+EA treatment groups (n = 7 per group). For blockade of TrkB signaling, the specific TrkB antagonist ANA-12 (0.5 mg/kg/day, 7 days, i.p.; Tocris Bioscience, Bristol, UK)43 (link) was administered 1 h prior to each EA session. EA was applied once daily for 7 consecutive days and MWM tests were performed 5 days after treatment initiation and 3 days after treatment completion. Experimental results were recorded using SMART, version 2.5.18 (Panlab S.L.U.). Mice were sacrificed and tissues were analyzed for MBP expression and BrdU incorporation after the final MWM test.
+ Open protocol
+ Expand
8

Intrahippocampal Injection of ANA-12 in Rats

Check if the same lab product or an alternative is used in the 5 most similar protocols
The female rats were anesthetized with 4% isoflurane in oxygen. The skull was exposed, and the head was positioned in a stereotaxic apparatus. A 10-μL Hamilton syringe (Hamilton, Bonaduz AG, Bonaduz, Switzerland) with a stainless needle was used to inject 0.1 pmol/1 μL ANA-12 (Tocris, Bristol, UK, pH 7.4 adjusted with NaOH) or aCSF into the hippocampus with an infusion pump (UMC4; World Precision Instruments, FL, USA) over the course of 2 min. The needle was left in place for another 5 min before removal, and the total procedure lasted 7 min. The coordinates for injection were as follows: anterior/posterior (AP) −3.8 mm, lateral (L) +/−2.0 mm, and dorsal/ventral (DV) −2.5 mm59 (link). The correct position of the needle was assessed by brain slide capture (Fig. 7a). The ANA-12 dose and administration method were based on a previous work60 (link). Postoperatively, the rats remained in a warm cage until they recovered.
+ Open protocol
+ Expand
9

Diabetes and Cardiac Biomarkers in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the present study, male db/db mice and male C57BL/6 mice were employed. The animals were maintained on the standard diet and these had free access to drinking water. The animals were kept in the polypropylene cages in the group of three (maximum) in the animal house at a temperature of 24°–26° with relative humidity of 40%–60%. The animals were exposed to 12 h light and dark cycle. The floor of the cages was covered with husk and each cage was cleaned completely every week. The Institutional Animal Care and Use Committee of Cadre Ward 901 Hospital of the Joint Logistics Support Unit of the Chinese People's Liberation Army approved the animal ethical protocol (Ethical approval number: 202000876A). All experiments related to animals were performed as per Institutional and International ethical guidelines. The kits for estimating the levels of creatine kinase (CK-MB), lactate dehydrogenase-1 (LDH-1) and cardiac troponin T (cTnT) were purchased from Jiancheng Reagent Co, Nanjing, China. The ELISA kits were employed for the quantification of BDNF, p-GSK-3β/GSK-3β and Nrf-2 (MyBioSource, Inc., San Diego, CA, USA). ANA-12 was employed as a specific BDNF receptor antagonist (Tocris Biosciences, Minneapolis, MN, USA). The doses of L-NAME [22 (link)] and ANA-12 [23 (link)] were used as per literature reports.
+ Open protocol
+ Expand
10

Neurotrophin and Receptor Antagonism Study

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cultured cells were incubated for 24 h with 40 μM NTS (Calbiochem/Merck Millipore, Fontenay sous Bois, France) or 100 ng/ml human recombinant BDNF (Alomone labs, Jerusalem, Israel). Optimal concentrations of exogenous BDNF and NTS were determined previously.14 (link), 21 (link) The non-peptide NTSR antagonist SR142948A (Tocris Biosciences, Bristol, UK) was used at 67 nM,56 (link) PTX (Sigma-Aldrich, St Louis, MO, USA) at 200 ng/ml35 (link), 57 (link); TrkB inhibitors were K252a (Alomone Labs) at 100 nM58 (link), 59 (link) or ANA12 (Tocris Biosciences) at 100 μM.60 (link)
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!